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Abstract: Other than genetic regulation of salt sensitivity of blood pressure, many factors have been
shown to regulate renal sodium handling which contributes to long-term blood pressure regulation
and have been extensively reviewed. Here we present our progress on the Na/K-ATPase signaling
mediated sodium reabsorption in renal proximal tubules, from cardiotonic steroids-mediated to
reactive oxygen species (ROS)-mediated Na/K-ATPase signaling that contributes to experimental
salt sensitivity.
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1. Introduction
According to the 2016 American Heart Association (AHA) Statistical Update [1], 32.6% (about
80 million) of people in the United States aged 20 and older have hypertension, and about 54.1%
of those cases have their hypertension well-controlled. Hypertension is a major risk factor for
cardiovascular events and mortalities. The development and maintenance of hypertension is
complicated. The causes are still not well defined in most hypertension cases (about 90%–95%). In the
2008 AHA Scientific Statement [2], excessive dietary salt ingestion contributes to the development and
maintenance of hypertension and tends to be more pronounced in older salt-sensitive people, African
Americans, and those with chronic kidney diseases [3–5]. In the 2016 AHA Scientific Statement [6],
salt sensitivity was defined as a physiological trait by which blood pressure (BP) changes are parallel
to changes in salt intake. In human beings, salt sensitivity is “a continuous, normally distributed
trait”. United States Department of Agriculture (USDA) Guidelines and AHA Scientific Statements
all suggest that a modest dietary salt reduction along with a balanced diet would be beneficial in
BP control.
Collectively, there are considerable amount of factors that regulate both BP acutely and chronically.
One major regulating factor is the kidney, which regulates systemic body fluid composition and
volume. Early studies with kidney cross-transplantation showed that “hypertension goes with
kidney” [7–11]. It is well accepted that renal sodium handling is a key determinant of long-term BP
regulation [2,12–14]. Along the nephron, renal proximal tubules (RPTs) claim over 60% reabsorption
of filtered sodium, which plays a critical role in the pathogenesis of salt-sensitive hypertension in
humans [15–21] and in animal models, including spontaneously hypertensive rats (SHR) [22–24], Dahl
salt-sensitive rats [25,26] and Milan hypertensive rats [27].
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2. The Concept of “Natriuretic Hormone” and Renal Sodium Handling
The concept of “natriuretic hormone” or “third factor” eliminating excessive sodium by direct
inhibition of Na/K-ATPase was proposed decades ago [28–31]. The concept of the “natriuretic
hormone” proposed that excessive dietary salt intake increases circulating endogenous digitalis-like
substances that are specific inhibitors and ligands of Na/K-ATPase. These substances can directly
inhibit renal tubular Na/K-ATPase, leading to inhibition of renal sodium reabsorption and an increase
in natriuresis to correct volume expansion and related BP increase. Accumulating evidence supports
this concept under pathophysiological conditions such as high salt intake, chronic renal failure and
chronic heart failure in various animal models and human beings [30,32–48]. The endogenous
digitalis-like substances, also known as cardiotonic steroids (CTS), were recently identified as
a new class of endogenous steroid hormones whose production and secretion are regulated by
many factors including angiotensin II, adrenocorticotropic hormone, high salt intake, volume
expansion, chronic renal failure and congestive heart failure [48–53]. Since the rodent Na/K-ATPase
α1 subunit is much more ouabain-resistant (insensitive to ouabain treatment) compared to other
ouabain-sensitive species such as dog, sheep and pig, the ouabain-induced natriuretic effect is more
profound in ouabain-sensitive species. Gene replacement studies (in which the ouabain-resistant
mouse Na/K-ATPase α1 subunit was replaced with ouabain-sensitive humanized α1 subunit) have
unequivocally demonstrated an important role of endogenous CTS in the regulation of renal sodium
excretion and BP in rodents [54,55]. CTS also cause significant oxidative stress and cardiovascular
remodeling independent of their effect on BP [56–59].
Renal sodium reabsorption is controlled by many hormones and neurotransmitters, including
parathyroid hormone (PTH), dopamine, epinephrine and norepinephrine, angiotensin II, insulin and
glucocorticoids (reviewed in [60]); Na/K-ATPase is the driving force by coupling with the rate-limiting
sodium-hydrogen exchanger (Na+/H+ exchanger isoform 3, NHE3). Accumulating evidence indicates
that the ion transport capacities (activities) of the Na/K-ATPase and NHE3 are mainly regulated
through protein trafficking under different conditions [61–65].
3. The Role of CTS in Na/K-ATPase Signaling Mediated RPT Sodium Handling
Ouabain (CAS# 630-60-4, C29H44O12) is a plant-derived CTS that can be found in
Acokanthera schimperi and Strophanthus gratus plants. Ouabain was also isolated and identified
in human plasma as an “endogenous hormone” [49,66]. With the discovery that the signaling
function of Na/K-ATPase is stimulated by low doses of ouabain, we investigate the Na/K-ATPase
signaling-mediated renal sodium handling and its role in salt-sensitive hypertension. Na/K-ATPase
signaling has been widely studied over almost two decades and has been discovered and verified in
different cells, tissues, organs and whole bodies. The topic has also been extensively reviewed.
In essence, CTS bind to the Na/K-ATPase α1 subunit (reviewed in [67]) and activate the α1
subunit-associated c-Src (which interacts with the Na/K-ATPase α1 subunit to form the receptor
Na/K-ATPase/c-Src complex), resulting in the stimulation of multiple protein-protein interactions
and multiple protein kinase cascades, including, but not limited to, c-Src kinase, extracellular
signal-regulated kinases 1 and 2 (ERK1/2), phosphoinositide-3 kinase (PI3K) and protein kinase
C (PKC), as well as increased reactive oxygen species (ROS) production in both in vitro and in vivo
models (reviewed in [32,35,36,48,52,68–77]). Even though the mechanism and the specific species
of ouabain-stimulated ROS still remain unclear, our observations suggest that ouabain stimulates
Ras-dependent, and at least in part, mitochondria-originated superoxide anion/hydrogen peroxide
production [78–80]. In this review, we use the general term “ROS” to express ouabain-stimulated ROS
increase. Increases in superoxide anion/hydrogen peroxide and reactive nitrogen species nitric oxide,
which are mainly produced by mitochondria, NADPH oxidase, xanthine oxidase and uncoupled NO
synthesis, can modify the Na/K-ATPase α and β subunit to inhibit the Na/K-ATPase enzymatic (ion
exchange) activity [81,82]. However, while ouabain has been shown to induce mitochondria-related
ROS generation [78,83], the role of NADPH oxidase, xanthine oxidase and uncoupled NO synthesis
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in the regulation of Na/K-ATPase signaling function is not clear. We will discuss the effect of
H2O2 on Na/K-ATPase signaling and carbonylation modification in detail later. At the low doses
without significant acute inhibition of the Na/K-ATPase ion-transport activity, ouabain-stimulated
Na/K-ATPase signaling is largely independent of the changes in intracellular Na+ and K+ concentration
activity demonstrated in rat neonatal myocytes and pig renal proximal tubule cell lines [78,84,85].
Using pig RPT cell line LLC-PK1 cells as a model, we found that a low concentration of ouabain
induces significant depletion of the basolateral membrane-bound Na/K-ATPase and decreases in
transcellular 22Na+ transport without intracellular Na+ changing [78,86,87]. Specifically, ouabain
stimulates Na/K-ATPase/c-Src signaling, leading to caveolin-1-dependent and clathrin-dependent
endocytosis of the Na/K-ATPase α1 subunit, a process mediated by activation of c-Src and PI3K
(phosphatidylinositol 3-kinase) [87,88]. Moreover, in male Sprague Dawley rats, a high-salt diet
(4% NaCl) increased urinary sodium and marinobufagenin (MBG, another cardiotonic steroid)
excretion, reduced proximal tubular Na/K-ATPase enzymatic activity and induced endocytosis
of the proximal tubular Na/K-ATPase α1 subunit. These effects were significantly attenuated by
administration of an anti-MBG antibody [89], suggesting that redistribution of Na/K-ATPase in
RPT epithelium in response to endogenous CTS might play an important role in renal adaptation to
salt loading.
With normal renal function, renal adaptations to volume expansion and dietary sodium intake
involve a marked downregulation of RPT sodium reabsorption. The Na/K-ATPase endocytosis
and reduction of transcellular Na+ transport without changes in intracellular Na+ concentration
suggest that ouabain might cause a physiological reduction of transcellular Na+ reabsorption. For this
mechanism to function in the physiological setting, however, the apical component of proximal
tubule Na+ reabsorption would also have to be negatively affected by ouabain. In polarized RPTs,
apical Na+ entry is mainly represented by NHE3, an apical membrane-bound sodium-hydrogen
exchanger [90]. NHE3 provides a critical mechanism for Na+, HCO3− and fluid reabsorption in the
RPTs [91,92]. NHE3 knockout mice showed reduced RPT Na+ and HCO3− reabsorption with urinary
Na+ and HCO3− wasting [91]. While increases in BP redistributed RPT NHE3 [93,94], chronic salt
loading downregulated RPT NHE3 [95]. Trafficking of NHE3 is regulated by changes in endocytosis
and/or exocytosis [96–99]. In epithelial cells, lipid rafts are involved in c-Src-dependent regulation
of NHE3, both in signaling and trafficking [100]. Depressing apical Na+ entry without hypertension
is not sufficient to decrease Na/K-ATPase activity, and depressing Na/K-ATPase activity alone is
not sufficient to decrease RPT Na+ reabsorption; thus, it was proposed that coordinated decreases
in both NHE3 surface distribution and Na/K-ATPase activity may be important for the response to
hypertension [65,101–103].
We have demonstrated that ligand-mediated RPT Na/K-ATPase/c-Src signaling regulates
RPT sodium reabsorption, and impairment of Na/K-ATPase/c-Src signaling contributes to
experimental salt-sensitive hypertension [26,85,86,88,89]. In LLC-PK1 cells, ouabain activates the
Na/K-ATPase/c-Src signaling pathway and coordinately stimulates the redistribution of basolateral
Na/K-ATPase and apical NHE3, which is dependent on c-Src, PI3K and caveolin-1. This regulation,
without influencing intracellular sodium concentration, leads to reduced transcellular 22Na+ transport
in RPTs. When this regulatory mechanism was tested in vivo in Dahl salt-sensitive rats and
salt-resistant rats fed a high-salt diet, the salt-resistant rats showed reduced sodium reabsorption
and increased total urinary and RPT-mediated fractional sodium excretion with the activation of
Na/K-ATPase signaling (interaction between the Na/K-ATPase α1 subunit with c-Src, activation of
c-Src and ERK1/2) and redistribution of the Na/K-ATPase and NHE3 in isolated RPTs. However,
the aforementioned observations in the salt-resistant rats were not seen or were significantly less in
the salt-sensitive rats with raised BP. Moreover, this mechanism was also shown in Sprague Dawley
rats [26,89]. This indicates that, in response to salt loading, activation of Na/K-ATPase signaling is
beneficial in the regulation of RPT sodium handling, leading to salt resistance, and impairment of the
signaling contributes to salt-sensitive hypertension.
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4. The Role of ROS in Na/K-ATPase Signaling Mediated RPT Sodium Handling
The different response of the Na/K-ATPase signaling to salt loading between the salt-resistant
and salt-sensitive rats could not be simply explained, since both strains have the same sequence
of the Na/K-ATPase α1 subunit (the predominant α isoform in RPTs) and the same content of salt
loading. This raised the question that other factor(s), except CTS, might activate or influence the
Na/K-ATPase signaling. We have observed that ouabain-stimulated Na/K-ATPase signaling increases
ROS generation, and pretreatment with antioxidants blocks the effects of ouabain [84]. ROS stress is
both a cause and a consequence of hypertension [104–108]. In kidneys, physiological ROS functions as
an important second messenger; but increased ROS influences RPT sodium handling [109–112], and
pathological ROS stress causes renal dysfunction [113,114]. In different animal models, administration
of antioxidants exhibits a beneficial effect on BP control (reviewed in [106]). In RPTs, increases in ROS
stress activate Na/K-ATPase signaling, leading to the redistribution of Na/K-ATPase and NHE3 from
membrane to cytosolic endosomes, which in turn reduces the capacity of sodium transport across
the RPTs by the reduction of sodium entry through apical NHE3 and extrusion through basolateral
Na/K-ATPase. This process reduces the sodium reabsorption and contributes to the development of
salt-sensitive and volume expansion-mediated hypertension [109,110,112,115–121].
Interestingly, both Na/K-ATPase and Src protein tyrosine kinases are redox-sensitive [122–127].
We have demonstrated that a sustained non-toxic level of H2O2 promotes ouabain-induced cellular
changes and endocytosis of Na/K-ATPase [128]. On the other hand, ROS stimulated by ouabain
functions as a downstream effector of Na/K-ATPase signaling [78,79,84,128]. We hypothesized that
Na/K-ATPase signaling is redox-sensitive, whereby ROS production induced either by CTS through
the Na/K-ATPase α1 subunit or by other stimuli is necessary for its signaling and the subsequent
inhibition of RPT sodium reabsorption (reviewed in [129]). However, chronic ROS overstimulation
may overstimulate oxidative modification of the Na/K-ATPase α1 subunit, rendering desensitization
of Na/K-ATPase signaling and, thus, dysregulation of RPT sodium reabsorption and BP.
In LLC-PK1 cells, ROS is clearly involved in the regulation of Na/K-ATPase signaling and
RPT sodium handling. An increase in ROS by glucose oxidase activates Na/K-ATPase/c-Src
signaling and redistributes Na/K-ATPase and NHE3, leading to inhibition of active transepithelial
22Na+ transport from the apical to basolateral aspect. Ouabain-induced activation of Na/K-ATPase
signaling requires a basal physiological range of ROS since blockage of ROS prevents the initiation
of ouabain-Na/K-ATPase signaling function. These observations suggest that ouabain-induced ROS
generation further stimulates Na/K-ATPase signaling through a positive feedback mechanism, as well
as that ROS is essential in initiating Na/K-ATPase signaling, and sufficient antioxidant capacity can
prevent Na/K-ATPase signaling [80]. In LLC-PK1 cells, both ouabain and glucose oxidase stimulate
direct protein carbonylation of the Pro222 and Thr224 amino acid residues of the Na/K-ATPase
α1 subunit [80,130]. It has been demonstrated that protein carbonylation can function as a means
of signal transduction, showing that ligand-receptor-mediated signaling promotes ROS-dependent
protein carbonylation and proteasome-dependent degradation of carbonylated proteins [131,132].
A single mutation of Pro222 to Ala (Pro224Ala in rat α1) does not affect ouabain-induced inhibition
of Na/K-ATPase enzymatic activity and ion-exchange activity, but abolishes the effects of ouabain
on Na/K-ATPase/c-Src signaling, carbonylation modification, Na/K-ATPase endocytosis and active
transepithelial 22Na+ transport. The data indicate that direct carbonylation modification of rat α1
Pro224 determines ouabain-mediated Na/K-ATPase signal transduction and subsequent regulation of
RPT sodium transport.
In rodents, infusion of CTS and renal 5/6th partial nephrectomy cause ROS stress and protein
oxidation in experimental animals [58,133]. Neutralization of CTS by administration of antibody
against marinobufagenin (MBG) has been shown to reduce natriuresis in response to a high salt diet [89].
Renal 5/6th partial nephrectomy and a high fat diet are known to induce oxidative stress in rodents,
leading to the development of experimental uremic cardiomyopathy and adipogenesis, respectively.
Recently, we have demonstrated that both manoeuvers activate Na/K-ATPase/c-Src signaling and
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cause carbonylation modification of proteins. Administration of pNaKtide (a peptide originated
from a segment of the Na/K-ATPase α1 subunit, functioning as an antagonist of Na/K-ATPase/c-Src
signaling), in both cases, blocks the signaling and carbonylation modification, as well as significantly
attenuates the phenotype of uremic cardiomyopathy by partial nephrectomy and adipogenesis by a
high fat diet [134,135].
5. The ROS Paradox
In Dahl salt-sensitive rats, salt induces increases in aortic superoxide (O2•−) mainly through an
angiotensin-dependent NADPH oxidase pathway; however, blockage of O2•− does not lower the
salt-induced increase in systolic BP [136,137].
In human beings, elevated endogenous CTS has been implied in aging-related salt sensitivity [138]
and about 50% of untreated essential hypertensive patients [139]. Human studies seem to support a role
of oxidative stress in the development of hypertension [104,106]. Hypertensive patients have increased
levels of oxidative stress byproducts together with lowered activity of endogenous antioxidant enzymes
in blood and mononuclear cells [140]. In comparison to control normotensive patients, hypertensive
patients have been shown to have a reduction in superoxide dismutase and glutathione peroxidase
activity, higher superoxide and hydrogen peroxide, which returned to control levels after BP reduction,
and higher lipid hydroperoxide production [141–144]. The Dietary Approaches to Stop Hypertension
(DASH) study and subsequent studies demonstrated that dietary pattern and salt intake interventions
lower BP, which is related to reducing oxidative stress and reducing dietary salt intake [145–148].
6. Conclusions and Perspective
Based on the observations of the interplay amongst CTS, ROS and Na/K-ATPase signaling,
we have proposed that Na/K-ATPase, along with its ion-pumping and signaling function, also
functions as an amplifier/receptor for oxidant signals, by coupling with c-Src (the Na/K-ATPase/c-Src
signaling complex) (Figure 1). While Na/K-ATPase is the specific target of CTS, oxidative stress
and CTS-induced increases in ROS can also target systems other than the Na/K-ATPase/c-Src
complex. Activation of this oxidant amplification loop would generate more and more ROS, raising
ROS from the physiological to the pathophysiological level, which will lead to over-stimulation
of Na/K-ATPase/c-Src signaling, which in turn, renders the signaling complex inactive to further
stimulation. This might also be the case of chronic oxidative stress in which Na/K-ATPase signaling is
insensitive to stimulation. By interrupting this amplification loop, pNaKtide antagonizes Na/K-ATPase
signaling-mediated oxidant amplification and oxidative modification of Na/K-ATPase and other
proteins, to relieve the overall oxidant stress to the physiological level that will restore the capability
of CTS-mediated Na/K-ATPase signal transduction [134,135]. On the other hand, in clinic trials,
antioxidant supplementation has been shown to be beneficial (such as combination antioxidant
supplement containing zinc, ascorbic acid, α-tocopherol and β-carotene, as well as glutathione
and vitamin C) [149–151], ineffective (such as a combination antioxidant supplement containing
ascorbic acid, synthetic vitamin E and β-carotene) [152] or even dangerous [106,153,154]. Using
general antioxidants might not be effective to bring oxidative stress to a physiological level (with
lower doses of antioxidants) or might totally naturalize ROS and bring cells into a sub-physiological
level or even a reducing state (with high overdoses of antioxidants) that will affect many normal
physiological functions at the cell/tissue/organ levels. There is no doubt about the association of
food and health. The U.S. Department of Agriculture/Department of Health and Human Services
2010 Dietary Guideline for Americans (available at https://health.gov/dietaryguidelines/) indicates
that certain supplements may be beneficial for certain special populations with some chronic diseases,
but excessive usage of certain supplements might be harmful. The impact of the usage of multiple
vitamins and minerals in individuals needs to be evaluated based on the individual’s health condition,
life style, genetics and other factors [155].
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Our observations indicate that the redox-sensitive Na/K-ATPase signaling contributes to salt
sensitivity by regulating sodium handling in renal proximal tubules. Targeting the Na/K-ATPase
signaling-mediated oxidant amplification loop might have therapeutic implications. Nevertheless, the
mechanism is still not totally clear and needs to be further investigated.Antioxidants 2017, 6, 18 6 of 13 
 
Figure 1: Illustration of the Na/K-ATPase signaling-mediated oxidant amplification loop, showing 
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stimulated oxidant amplification loop. Increases in CTS alone or increases in ROS alone or a 
combination of increases in CTS and ROS (not shown) stimulate Na/K-ATPase/c-Src signaling to 
induce Na/K-ATPase signaling-mediated events, such as renal sodium handling in proximal tubules 
(natriuresis), PNx-induced uremic cardiomyopathy and a high fat diet-induced adipogenesis.  
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